02 September 2022 | NewsVideo now available | NCIRS webinar - Emerging vaccine preventable diseases and vaccination for travelRead the full article
The impact of shingles (herpes zoster) and its complications can be severe and long lasting however vaccination is a safe and effective way to protect against this disease in most people.
Influenza and COVID-19 vaccination encounters over the coming months may offer an opportunity to discuss this important vaccine with those eligible.
Watch the recording of our webinar to:
Speakers and presentations:
Professor Kristine Macartney MBBS, BMedSci, MD, FRACP
Kristine Macartney is a paediatrician and infectious disease specialist. She is a medical graduate of the University of New South Wales and has over 20 years of experience in vaccinology.
She has experience working in the USA at the Children’s Hospital of Philadelphia where she was a founding member of the US Vaccine Education Center. Her Doctorate of Medicine was on rotavirus infection, in particular the mucosal immune response to novel vaccine candidates. She is interested in all aspects of vaccine preventable disease research, particularly policy development, vaccine safety and prevention of viral diseases. She is the senior editor of The Australian Immunisation Handbook. Kristine is a staff specialist in Infectious Diseases and Microbiology at The Children’s Hospital at Westmead and has a conjoint academic appointment as professor in the Discipline of Child and Adolescent Health, University of Sydney.
Professor Anthony (Tony) Cunningham AO, FAHMS, MD, FRACP, FRCPA
Director, Centre for Virus Research, Westmead Institute for Medical Research
Professor Anthony (Tony) Cunningham is an infectious diseases physician, clinical virologist and scientist, well known internationally for his research on the immunology of HIV and herpesviruses, his work on vaccine development and trialling, and as an antivirals expert.
Tony is the director of the Centre for Virus Research at the Westmead Institute for Medical Research; professor and vaccine theme leader in the Sydney Infectious Diseases Institute of the University of Sydney; and director of the Australian Centre for HIV and Hepatitis Virology Research. Tony has extended his research to COVID-19 vaccine development and trialling, funded by state and national grants, assuming other advisory positions to government in this field.
Associate Professor Bette Liu MBBS(Hons) MPH(Hons) DPhil(Oxon)
Staff specialist, Immunisation, NCIRS
Bette Liu is a medically trained epidemiologist with extensive national and international experience in the design, conduct and analysis of large-scale epidemiological studies using record linkage of administrative heath data and e-medical records. She trained in medicine and public health at the University of Sydney and obtained her doctorate in epidemiology from the University of Oxford. Bette Liu is an associate professor in the School of Population Health at the University of New South Wales. Her research is focused on the control of communicable diseases and vaccine preventable diseases in adult populations.